Christopher Seiter
Plus aucun poste en cours
Profil
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Anciens postes connus de Christopher Seiter
| Sociétés | Poste | Fin |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Directeur Financier/CFO | 02/04/2021 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Directeur Financier/CFO | - |
Formation de Christopher Seiter
| Rochester Christian University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
| Bank of America Merrill Lynch (New York) |
